Safest Choice of Antihypertensive Regimen for Postpartum Hypertension — SCARPH  

High Blood Pressure Clinical Trial

Official title: Safest Choice of Antihypertensive Regimen for Postpartum Hypertension: A Randomized Control Trial (SCARPH)

Status Recruiting

Clinical Trial Summary

The purpose of this investigator-initiated randomized control trial is to determine whether oral Nifedipine versus oral Labetalol is superior in controlling high blood pressures in the postpartum period.

Clinical Trial Description

High blood pressure (hypertension) is one of the most common medical disorders in pregnancy and affects 10% of all pregnancies in the United States, with possible short-term and long-term health complications including increased risk of stroke, and liver, kidney, and heart disease. Management of severe high blood pressure after delivery involves medications to lower blood pressure, strict discharge instructions and close follow- up after delivery. Both oral Nifedipine and oral Labetalol are considered safe agents for the treatment of postpartum high blood pressure, however few studies exist that directly compare the two. The investigators want to conduct this study because they want to compare the effects of oral Nifedipine or oral Labetalol on postpartum hypertension. In this study, subjects will get either oral Nifedipine or oral Labetalol. Subjects will not get both. No experimental drugs or devices will be used. ;

Related Conditions & MeSH terms

• High Blood Pressure
• Hypertension
• Maternal Hypertension

• NCT number: NCT05551104
• Study type: Interventional
• Source: Loma Linda University
• Contact: Ashra Denise B Tugung, BSc
• Phone: 9096515580
• Email: atugung@llu.edu
• Status: Recruiting
• Phase: Phase 3
• Start date: December 2024
• Completion date: December 2027